Schizophrenia; Psychosis
Neurology·MeSH: Schizophrenia
Prevalence
348.2 / 100K
Incidence
21.8 / 100K/yr
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| xanomeline/trospium | GH Research PLC (GHRS) |
Phase 4(1)
| Drug | Company |
|---|---|
| KarXT | BRISTOL MYERS SQUIBB CO (BMY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Schizophrenia; Psychosis?
BioSniper tracks 2 drugs in development for Schizophrenia; Psychosis across 2 companies.
How many clinical trials target Schizophrenia; Psychosis?
There are 1 clinical trial targeting Schizophrenia; Psychosis tracked by BioSniper.
What is the prevalence of Schizophrenia; Psychosis?
The estimated prevalence of Schizophrenia; Psychosis is approximately 348.2 per 100,000 population.
Deep-dive into Schizophrenia; Psychosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis